OXO, Inc 8-K

What Happened

• OXO, Inc filed a Form 8‑K on June 16, 2026 reporting that on June 12, 2026 it entered an exclusive License and Research Collaboration Agreement with The University of Edinburgh (via Edinburgh Innovations Limited). The Agreement grants OXO an exclusive, worldwide, royalty‑bearing license to the University’s proprietary software, algorithms, and analytical frameworks for Marketing Mix Modeling (MMM), marketing attribution, digital marketing analytics, predictive consumer behavior analytics, campaign optimization, and related SaaS platforms.

Key Details

• Initial non‑refundable license fee: $30,000, payable within 10 business days of execution.
• Sponsored Research Program: OXO will fund $180,000 per year for three years beginning Sept. 1, 2026, paid quarterly ($45,000 per quarter); up to $30,000/year may be used for international patent filings (UKIPO, EPO, WIPO).
• Royalties and sublicensing: OXO pays a 2% running royalty on gross revenues from its own commercial offerings using the Licensed Technology; the University receives 10% of revenues from any sublicenses, partner, or reseller arrangements.
• Other economics and term: Escalating maintenance fees ($10k/year from Jan. 1, 2029; $25k from Jan. 1, 2031; $50k from Jan. 1, 2034); equity issuance of common shares equal to 3% of fully diluted outstanding common stock upon a Qualified Financing of at least $1.5M; initial 20‑year term with automatic one‑year renewals.

Why It Matters

• The deal gives OXO exclusive rights to university IP in marketing analytics and related SaaS, supporting product development or commercial offerings that could drive future revenue.
• The Agreement creates recurring cash commitments (research funding starting Sept. 2026 and ongoing royalties/maintenance fees) that investors should track as operating expenses and potential margin impacts.
• There is potential shareholder dilution if OXO completes a qualifying financing (3% issuance to the University). The full License and Research Collaboration Agreement will be filed as an exhibit to OXO’s next periodic report for complete terms.